| P2093 | author name string | H. W. Kreth | |
| | V. Schuster | |
| P2860 | cites work | Epstein-Barr virus-associated lymphoproliferative syndromes: studies in two European families | Q68238876 |
| | Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease | Q69328485 |
| | X-linked lymphoproliferative syndrome | Q69365148 |
| | Linkage analysis of seven kindreds with the X-linked lymphoproliferative syndrome (XLP) confirms that the XLP locus is near DXS42 and DXS37 | Q69371097 |
| | Relationship of immunodeficiency to lymphoid malignancy | Q69833427 |
| | Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS | Q69874991 |
| | Detection of active Epstein-Barr infection in pregnant women | Q70092635 |
| | Hairy leukoplakia in a child | Q70392677 |
| | Recurrence of infectious mononucleosis | Q72422594 |
| | Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas | Q72586693 |
| | Recurrent mononucleosis | Q79577400 |
| | CULTIVATION IN VITRO OF HUMAN LYMPHOBLASTS FROM BURKITT'S MALIGNANT LYMPHOMA | Q52829769 |
| | Advances in the diagnosis and treatment of EBV-associated lymphoproliferative diseases in immunocompromised hosts. | Q53541147 |
| | Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis. | Q55242223 |
| | Partial Xq25 deletion in a family with the X-linked lymphoproliferative disease (XLP) | Q68090741 |
| | Isolation of a new herpesvirus from human CD4+ T cells | Q24559852 |
| | Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis | Q24632165 |
| | Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency | Q24645115 |
| | Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders | Q28282589 |
| | Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency | Q33445040 |
| | Epstein-Barr virus infectious mononucleosis in children. I. Clinical and general laboratory findings | Q33445064 |
| | In Utero Epstein-Barr Virus (Infectious Mononucleosis) Infection | Q33476763 |
| | Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells | Q33929593 |
| | The switch between latency and replication of Epstein-Barr virus | Q34185438 |
| | The history of infectious mononucleosis | Q34207772 |
| | Persistent Epstein-Barr virus infection and pregnancy. | Q34254546 |
| | Oligoclonal T cell receptor gene rearrangements in blood lymphocytes of patients with acute Epstein-Barr virus-induced infectious mononucleosis | Q34262343 |
| | Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy | Q34330594 |
| | Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection | Q34467595 |
| | Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome | Q34552319 |
| | Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells | Q34564031 |
| | Mapping the X-linked lymphoproliferative syndrome | Q34609935 |
| | A non-X-linked syndrome with susceptibility to severe epstein-barr virus infections | Q45800510 |
| | Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation | Q45800684 |
| | Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus | Q45800949 |
| | Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies | Q45801131 |
| | Simultaneous congenital infection with Epstein-Barr virus and cytomegalovirus | Q45802181 |
| | Wiskott-Aldrich syndrome and Epstein-Barr virus-induced lymphoproliferation | Q45806064 |
| | T-cell control of Epstein–Barr virus-infected B cells is lost during P. falciparum malaria | Q45807134 |
| | Seroepidemiologic studies of infectious mononucleosis with EB virus | Q45814584 |
| | Prevalence, incidence and persistence of EB virus antibody in young adults | Q45822766 |
| | Activated lymphocytes during acute Epstein-Barr virus infection | Q45833905 |
| | Human epithelial cell expression of an Epstein-Barr virus receptor | Q45835276 |
| | The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. | Q45835618 |
| | Geographical prevalence of two types of Epstein-Barr virus | Q45836134 |
| | Infection with two genotypes of Epstein-Barr virus in an infant with AIDS and lymphoma of the central nervous system | Q45837254 |
| | Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion | Q45837679 |
| | A second site for Epstein-Barr virus shedding: the uterine cervix | Q45840059 |
| | Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. | Q45841044 |
| | Isolation of a normal B cell subset with a Burkitt-like phenotype and transformation in vitro with Epstein-Barr virus | Q45841225 |
| | Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus | Q45841360 |
| | Burkitt lymphoma in a child with human immunodeficiency virus infection | Q45842060 |
| | Detection of a second widespread strain of Epstein-Barr virus | Q45844566 |
| | Epstein-Barr virus latent gene expression during the initiation of B cell immortalization | Q45845786 |
| | Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2). | Q45847427 |
| | Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients | Q45851583 |
| | Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin's disease by in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAMeX) sections | Q45855097 |
| | Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma | Q45855621 |
| | Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3. | Q45859930 |
| | Chromosome translocation and c-MY Cactivation by Epstein-Barr virus and Euphorbia tirucalli in B lymphocytes | Q45860666 |
| | Epstein-Barr-virus-carrying lymphoma in a patient with ataxia-telangiectasia | Q34777403 |
| | Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection | Q35160206 |
| | Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2 | Q36273277 |
| | Epstein-Barr virus and human diseases: recent advances in diagnosis | Q36633160 |
| | Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21). | Q36866420 |
| | Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. | Q36873046 |
| | Biomolecular analysis of a defective nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection | Q36919438 |
| | Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses | Q37737223 |
| | Viral latency and transformation: the strategy of Epstein-Barr virus | Q38281598 |
| | Circulating Epstein-Barr virus-carrying B cells in acute malaria | Q39158105 |
| | X-linked recessive progressive combined variable immunodeficiency (Duncan's disease) | Q39324844 |
| | Role of epithelium in EBV persistence and pathogenesis of B-cell tumours | Q39467205 |
| | Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients. | Q39504173 |
| | Molecular basis of human B cell neoplasia | Q39813214 |
| | Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity | Q40059138 |
| | The changing faces of EBV research | Q40077032 |
| | Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patients | Q40078370 |
| | Epstein-Barr virus infections during pregnancy. A prospective study and review of the literature. | Q40134767 |
| | Persistence of Epstein-Barr virus in the parotid gland | Q40140673 |
| | Epstein-Barr virus and the X-linked lymphoproliferative syndrome | Q40141392 |
| | Primary epstein-barr virus infections in african infants. I. Decline of maternal antibodies and time of infection | Q40178507 |
| | Epstein-Barr virus-related antibody patterns in ataxia-telangiectasia | Q40223086 |
| | Virus-associated hemophagocytic syndromeA benign histiocytic proliferation distinct from malignant histiocytosis | Q40251317 |
| | Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis | Q40751741 |
| | Epstein-Barr virus infection rapidly progressing to monoclonal lymphoproliferative disease in a child with selective immunodeficiency | Q40757465 |
| | Severe chronic active Epstein-Barr virus infection syndrome and adenovirus type-2 infection | Q40767494 |
| | Fatal infectious mononucleosis with staphylococcal pyoderma in a girl with hereditary immunological dysregulations | Q40768936 |
| | Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection | Q40774717 |
| | Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease | Q40785638 |
| | T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections | Q40787633 |
| | X-linked lymphoproliferative syndrome. Identification of a large family in Switzerland | Q41284038 |
| | The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children | Q41453710 |
| | Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects | Q41723351 |
| | An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3) | Q41757439 |
| | Inhibition of Epstein-Barr virus infection in vitro by recombinant human interferons alpha and gamma | Q41991258 |
| | Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants | Q42068985 |
| | Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance | Q42818302 |
| | Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes | Q43679392 |
| | The clinico-pathological expressions of Epstein-Barr virus infection in lymphoid tissues | Q43808236 |
| | Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease | Q43936463 |
| | Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis | Q43974065 |
| | Epstein-Barr virus-associated hemophagocytic syndrome: virological and immunopathological studies. | Q44165516 |
| | Methods of detection of new families with X-linked lymphoproliferative disease | Q44703956 |
| | Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies | Q44784556 |
| | Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma | Q44939914 |
| | Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals | Q44953164 |
| | Clonal T-cell lymphoproliferation containing Epstein-Barr (EB) virus DNA in a patient with chronic active EB virus infection | Q45142119 |
| | Epstein-Barr virus gene expression in nasopharyngeal carcinoma | Q45205828 |
| | Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells | Q45796774 |
| | Epstein-Barr virus infections in pregnancy: A prospective study | Q45796799 |
| | Study Of Epstein Barr Virus (Eby) Antibodies: IgG AND lgM Anti -VCA, lgG Anti-Ea and lgAnti-Ebna Obtained with an Original Microtiter Technique: Serological Criterions of Primary and Recurrent Eby Infections and Follow-Up of Infectious Mononucleosis | Q45799014 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 718-725 | |
| P577 | publication date | 1992-10-01 | |
| P1433 | published in | European Journal of Pediatrics | Q15755736 |
| P1476 | title | Epstein-Barr virus infection and associated diseases in children. I. Pathogenesis, epidemiology and clinical aspects | |
| P478 | volume | 151 | |